ArticleJournal of personalized medicine2022

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients.

Christina T Grech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.